Identification |
Name: | 1-Piperidinepropanol, a-cyclohexyl-a-phenyl-, hydrochloride (1:1) |
Synonyms: | 1-Piperidinepropanol,a-cyclohexyl-a-phenyl-, hydrochloride(6CI,7CI,8CI,9CI);1-Phenyl-1-cyclohexyl-3-piperidyl-1-propanol hydrochloride;3-(1-Piperidyl)-1-cyclohexyl-1-phenyl-1-propanol hydrochloride;Benzhexolhydrochloride;Broflex;Paralest;Pargitan;Parkinol;Parkisan;Partigan;Pipanol;Sedrina;Trihexy;Trihexyphenidyl chlorhydrate;Triphedinon;Triphenidyl;Tsiklodol;a-Cyclohexyl-a-phenyl-1-piperidinepropanolhydrochloride; |
CAS: | 52-49-3 |
EINECS: | 200-142-5 |
Molecular Formula: | C20H32ClNO |
Molecular Weight: | 337.93 |
InChI: | InChI=1/C20H31NO.ClH/c22-20(18-10-4-1-5-11-18,19-12-6-2-7-13-19)14-17-21-15-8-3-9-16-21;/h1,4-5,10-11,19,22H,2-3,6-9,12-17H2;1H |
Molecular Structure: |
|
Properties |
Transport: | 3249 |
Melting Point: | 258.5 |
Flash Point: | 211°C |
Boiling Point: | 447.9°Cat760mmHg |
Density: | g/cm3 |
Solubility: | In water, 18 mg/L at 25 deg C (est) |
Packinggroup: | III |
Flash Point: | 211°C |
Color: | white |
Usage: | An antiparkinsonian drug of the antimuscarinic class. |
Safety Data |
|
|